Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cytek Biosciences, Inc. - Common Stock (NQ:CTKB)

5.150 -0.190 (-3.56%)
Delayed Quote Updated: 10:58 AM EDT, Oct 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cytek Biosciences, Inc. - Common Stock

< Previous 1 2 3 Next >
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
Cytek (CTKB) Q2 2026 Earnings Call Transcript ↗
U.S. revenue surged 18% while EMEA declined 8% amid geopolitical pressures. 
Via The Motley Fool
Topics Earnings Intellectual Property World Trade
News headline image
Cytek Biosciences Q2 Earnings Call Highlights ↗
Cytek Biosciences (NASDAQ:CTKB) reported second-quarter 2026 revenue growth of 6% year over year, supported by double-digit gains in the United States and China, while continued weakness in Europe and... 
Via MarketBeat
Topics Earnings
Cytek Biosciences Inc (NASDAQ:CTKB) Reports Q4 2025 Revenue Beat and Mixed Earnings ↗
Via Chartmill
News headline image
Earnings Scheduled For November 5, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 6, 2025 ↗
 
Via Benzinga
News headline image
Beyond The Numbers: 4 Analysts Discuss Cytek Biosciences Stock ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 27, 2025 ↗
 
Via Benzinga
News headline image
Cytek (CTKB) Q1 2026 Earnings Call Transcript ↗
Cytek (CTKB) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Cytek (CTKB) Q4 2025 Earnings Call Transcript ↗
Cytek (CTKB) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings Intellectual Property World Trade
News headline image
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Preview: Cytek Biosciences's Earnings ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for Cytek Biosciences ↗
 
Via Benzinga
News headline image
Cytek (CTKB) Q3 2025 Earnings Call Transcript ↗
Cytek (CTKB) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings Intellectual Property World Trade
News headline image
DHT Holdings Posts Weak Sales, Joins Compass Diversified, Okta And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Nasdaq Down Over 100 Points; US Pending Home Sales Increase In November ↗
 
Via Benzinga
News headline image
Crude Oil Gains 1%; Chicago PMI Falls In December ↗
 
Via Benzinga
News headline image
Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Nasdaq Surges Over 500 Points; Johnson Controls Earnings Top Views ↗
 
Via Benzinga
News headline image
Gold Down Over 2%; CVS Health Shares Jump After Q3 Results ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Mercury Systems Posts Strong Results, Joins ArcBest, Tesla, Kennametal, Qualys And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
CTKB Stock Earnings: Cytek Biosciences Misses EPS, Misses Revenue for Q2 2024 ↗
CTKB stock results show that Cytek Biosciences missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
CTKB Stock Earnings: Cytek Biosciences Misses EPS, Beats Revenue for Q1 2024 ↗
CTKB stock results show that Cytek Biosciences missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
CTKB Stock Earnings: Cytek Biosciences Beats Revenue for Q4 2023 ↗
CTKB stock results show that Cytek Biosciences beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday ↗
U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday. 
Via Benzinga
Topics Stocks
News headline image
Cytek's Full Spectrum Technology Stands Out In Cell Analysis Market, Bullish Analyst Says ↗
Stephens initiated coverage on Cytek Biosciences Inc (NASDAQ: CTKB), a manufacturer and supplier of flow cytometry products and services.  
Via Benzinga
Topics Supply Chain
News headline image
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.